Picture

BioNTech SE @BioNTech_Group

Our vision: Harnessing the immune system’s power to turn science into survival. Data Privacy: https://t.co/ZHMXceTxRG Imprint: https://t.co/VNRPNHg7b0 biontech.com Mainz, Germany Joined November 2018
  • Tweets
    293
  • Followers
    81K
  • Following
    161
  • Likes
    44
BioNTech_Group Profile Picture

BioNTech SE @BioNTech_Group

3 weeks ago

Global interim Phase 2 data in extensive-stage small cell lung cancer presented at #WCLC25: Investigational approach designed to target PD-L1 and VEGF-A in a single molecule. Full PR: bit.ly/3I1dZVs

BioNTech_Group Profile Picture

BioNTech SE @BioNTech_Group

4 months ago

We are partnering with @bmsnews to jointly develop and commercialize our PD-L1xVEGF bispecific #antibody candidate BNT327. Combining our expertise, resources, and global reach, we aim to bring novel combination therapies to patients with #cancer. 🚀 investors.biontech.de/news-releases/…

BioNTech_Group Profile Picture

BioNTech SE @BioNTech_Group

6 months ago

We aim to tackle one of the most lethal cancers worldwide: #LungCancer. This week, we are joining the global community at the #ELCC25 presenting new data for our PD-L1/VEGF-A bispecific antibody candidate in metastatic #SCLC. 👉Learn more about the data: investors.biontech.de/encrypted-node…

BioNTech_Group Profile Picture

BioNTech SE @BioNTech_Group

11 months ago

Advancing our oncology strategy: by strengthening next-gen immuno-modulator capabilities, we’re enhancing one core pillar of our oncology strategy.With investigational assets like BNT327/PM8002,our pipeline aims to build a new backbone in immuno-oncology.investors.biontech.de/de/news-releas…

BioNTech_Group Profile Picture

BioNTech SE @BioNTech_Group

a year ago

We are excited to present updates for our #oncology pipeline at #ESMO24. Presentations feature candidates across multiple modalities which are important backbones for our combination treatment strategy & may open up new synergistic mechanisms of action.👉investors.biontech.de/news-releases/…

BioNTech_Group Profile Picture

BioNTech SE @BioNTech_Group

a year ago

We have just announced that our personalized #mRNA candidate BNT111 met its primary endpoint in randomized Ph 2 trial, demonstrating a statistically significant improvement in ORR in patients with anti-PD1 refractory/resistant #melanoma. 👉Read more: investors.biontech.de/news-releases/…

BioNTech_Group Profile Picture

BioNTech SE @BioNTech_Group

a year ago

The @US_FDA granted Fast Track designation for our #ADC candidate BNT324/DB-1311 for the treatment of castration-resistant #ProstateCancer. With this, all 3 clinical ADC candidates in our collab with #DualityBio have received Fast Track designation. investors.biontech.de/news-releases/…

Trends for United States

Nicki
482 B posts
The Twitter Give
343 B posts
Aces
35,2 B posts
Fever
46,1 B posts
Dodgers
92,8 B posts
#governmentshutdown2025
1.857 posts
Kelsey Mitchell
7.954 posts
Happy New Month
110 B posts
Independence Day
34,9 B posts
#DWTS
40,1 B posts
Odyssey Sims
3.808 posts
Sora 2
27,3 B posts
Boone
28 B posts
#NigeriaAt65
3.784 posts
WNBA
96,8 B posts
Lauren
61,3 B posts
GiveRep V1
Jackie Young
4.148 posts
Kulture
41,8 B posts
A'ja Wilson
7.665 posts

You might like

Our mission is to deliver the greatest possible impact to people through mRNA medicines.
Moderna
@moderna_tx
144K Followers
We’re celebrating over 175 years of daring scientific innovation and we’re not done yet. Protect your health at https://t.co/x7nTQbKL8w https://t.co/FPP9fmzZh6
Pfizer Inc.
@pfizer
477K Followers
President of the @EU_Commission. Mother of seven. Brussels-born. European by heart. 🇪🇺
Ursula von der Leyen
@vonderleyen
1.7M Followers
Our posts are FDA Approved! Privacy Policy - https://t.co/LbTJXYRXVP FDA Authentic Accounts - https://t.co/w2LNbzG7M0
U.S. FDA
@US_FDA
578K Followers
We're transforming the future of healthcare by unlocking the power of what science can do. Community Guidelines: https://t.co/Kh08zUdFpT
AstraZeneca
@AstraZeneca
295K Followers
Producing next-generation vaccines to help protect health through partnerships and R&D. See what’s developing at https://t.co/KU31yMhv7w & https://t.co/vOlgl99GU0
Novavax
@Novavax
61K Followers
Uniting caring with discovery to create medicines that make life better worldwide. Lilly’s official account (formerly LillyPad) https://t.co/oXewUD8FZI
Eli Lilly and Company
@EliLillyandCo
144K Followers
The official X channel dedicated to media and communications from Pfizer. To see all of our posts, please follow @pfizer.
Pfizer Inc.
@pfizer_news
34K Followers
Hier twittert die Online-Redaktion des Paul-Ehrlich-Instituts, Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel. https://t.co/jttaqmfnkM
Paul-Ehrlich-Institut
@PEI_Germany
27K Followers
Official channel for Regeneron. We turn science into medicine for people with serious diseases. View our terms of engagement here: https://t.co/EuFDUdQQ5E
Regeneron
@Regeneron
33K Followers
We're transforming the future of healthcare by unlocking the power of what science can do. Intended for US HCPs. For info visit https://t.co/1B0LbPwpeO
AstraZenecaUS
@AstraZenecaUS
81K Followers
We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://t.co/NdSNH7YhFc
GSK
@GSK
237K Followers
We work every day to transform patients’ lives through science. See our community guidelines: https://t.co/Qd22DZ1dFw
Bristol Myers Squibb
@bmsnews
153K Followers
Official global handle sharing the latest news about our company, science & people. Review our guidelines: https://t.co/AY8CXTtpuM
AbbVie
@abbvie
79K Followers
We advance science so that we all have more time with the people we love. Read our community guidelines: https://t.co/7k1HdbdrYL
Roche
@Roche
241K Followers